Sherpa Clinical Package

Allele Biotechnology is a pioneering provider of cGMP-induced pluripotent stem cells (iPSCs) and cell therapy contract development and manufacturing organization (CDMO) services, dedicated to advancing immuno-oncology and regenerative medicine. With over a decade of experience, the company offers a range of solutions from off-the-shelf iPSC lines to custom development, ensuring consistency, scalability, and cost-effectiveness in cell therapy programs. Utilizing a patented mRNA reprogramming system, Allele generates high-quality iPSCs that are footprint-free, feeder-free, and xeno-free, minimizing potential genomic risks. Their commitment to strict regulatory standards facilitates a smooth transition from scientific development to commercial deployment, making them a comprehensive partner for researchers and biopharma companies alike. Generated from the website

Crinetics Pharmaceuticals is a San Diego-based pharmaceutical company dedicated to developing innovative therapies for patients with endocrine diseases. With a focus on conditions such as acromegaly and carcinoid syndrome, the company aims to provide effective disease control and improve the quality of life for those affected by these rare disorders. Committed to addressing unmet medical needs, Crinetics partners with healthcare practitioners to ensure that its therapies solve real problems in patient care. The company emphasizes a culture of focused intensity, embracing challenges in its mission to bring cutting-edge science to underserved patient populations. Generated from the website